Logo image of OR.PA

L'OREAL (OR.PA) Stock Fundamental Analysis

EPA:OR - FR0000120321 - Common Stock

397.9 EUR
-4.45 (-1.11%)
Last: 8/29/2025, 7:00:00 PM
Fundamental Rating

6

Overall OR gets a fundamental rating of 6 out of 10. We evaluated OR against 13 industry peers in the Personal Care Products industry. OR has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. OR is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

In the past year OR was profitable.
In the past year OR had a positive cash flow from operations.
Each year in the past 5 years OR has been profitable.
Each year in the past 5 years OR had a positive operating cash flow.
OR.PA Yearly Net Income VS EBIT VS OCF VS FCFOR.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

1.2 Ratios

OR has a Return On Assets of 11.37%. This is amongst the best in the industry. OR outperforms 84.62% of its industry peers.
OR has a better Return On Equity (19.34%) than 76.92% of its industry peers.
With an excellent Return On Invested Capital value of 15.97%, OR belongs to the best of the industry, outperforming 84.62% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for OR is above the industry average of 12.46%.
Industry RankSector Rank
ROA 11.37%
ROE 19.34%
ROIC 15.97%
ROA(3y)11.83%
ROA(5y)10.87%
ROE(3y)20.54%
ROE(5y)18.68%
ROIC(3y)16.33%
ROIC(5y)15.46%
OR.PA Yearly ROA, ROE, ROICOR.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

1.3 Margins

OR's Profit Margin of 14.74% is amongst the best of the industry. OR outperforms 92.31% of its industry peers.
In the last couple of years the Profit Margin of OR has grown nicely.
OR's Operating Margin of 19.98% is amongst the best of the industry. OR outperforms 84.62% of its industry peers.
In the last couple of years the Operating Margin of OR has remained more or less at the same level.
OR has a Gross Margin of 74.18%. This is amongst the best in the industry. OR outperforms 92.31% of its industry peers.
In the last couple of years the Gross Margin of OR has remained more or less at the same level.
Industry RankSector Rank
OM 19.98%
PM (TTM) 14.74%
GM 74.18%
OM growth 3Y1.46%
OM growth 5Y1.47%
PM growth 3Y1.16%
PM growth 5Y3.26%
GM growth 3Y0.14%
GM growth 5Y0.32%
OR.PA Yearly Profit, Operating, Gross MarginsOR.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

8

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), OR is creating value.
The number of shares outstanding for OR remains at a similar level compared to 1 year ago.
Compared to 5 years ago, OR has less shares outstanding
Compared to 1 year ago, OR has an improved debt to assets ratio.
OR.PA Yearly Shares OutstandingOR.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M
OR.PA Yearly Total Debt VS Total AssetsOR.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B 50B

2.2 Solvency

An Altman-Z score of 7.36 indicates that OR is not in any danger for bankruptcy at the moment.
OR has a Altman-Z score of 7.36. This is amongst the best in the industry. OR outperforms 84.62% of its industry peers.
OR has a debt to FCF ratio of 1.28. This is a very positive value and a sign of high solvency as it would only need 1.28 years to pay back of all of its debts.
The Debt to FCF ratio of OR (1.28) is better than 84.62% of its industry peers.
OR has a Debt/Equity ratio of 0.20. This is a healthy value indicating a solid balance between debt and equity.
OR has a better Debt to Equity ratio (0.20) than 84.62% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.2
Debt/FCF 1.28
Altman-Z 7.36
ROIC/WACC2.07
WACC7.71%
OR.PA Yearly LT Debt VS Equity VS FCFOR.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B

2.3 Liquidity

OR has a Current Ratio of 1.13. This is a normal value and indicates that OR is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.13, OR is doing worse than 61.54% of the companies in the same industry.
A Quick Ratio of 0.81 indicates that OR may have some problems paying its short term obligations.
OR's Quick ratio of 0.81 is in line compared to the rest of the industry. OR outperforms 46.15% of its industry peers.
The current and quick ratio evaluation for OR is rather negative, while it does have excellent solvency and profitability. These ratios do not necessarly indicate liquidity issues and need to be evaluated against the specifics of the business.
Industry RankSector Rank
Current Ratio 1.13
Quick Ratio 0.81
OR.PA Yearly Current Assets VS Current LiabilitesOR.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

4

3. Growth

3.1 Past

OR shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 3.41%.
Measured over the past years, OR shows a quite strong growth in Earnings Per Share. The EPS has been growing by 10.34% on average per year.
Looking at the last year, OR shows a small growth in Revenue. The Revenue has grown by 2.60% in the last year.
Measured over the past years, OR shows a small growth in Revenue. The Revenue has been growing by 7.80% on average per year.
EPS 1Y (TTM)3.41%
EPS 3Y12.8%
EPS 5Y10.34%
EPS Q2Q%1.29%
Revenue 1Y (TTM)2.6%
Revenue growth 3Y10.44%
Revenue growth 5Y7.8%
Sales Q2Q%1.59%

3.2 Future

OR is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 8.27% yearly.
Based on estimates for the next years, OR will show a small growth in Revenue. The Revenue will grow by 5.26% on average per year.
EPS Next Y4.39%
EPS Next 2Y5.99%
EPS Next 3Y6.5%
EPS Next 5Y8.27%
Revenue Next Year2.4%
Revenue Next 2Y3.58%
Revenue Next 3Y4.11%
Revenue Next 5Y5.26%

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
OR.PA Yearly Revenue VS EstimatesOR.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 20B 40B 60B
OR.PA Yearly EPS VS EstimatesOR.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 5 10 15 20

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 31.21, which means the current valuation is very expensive for OR.
Compared to the rest of the industry, the Price/Earnings ratio of OR indicates a slightly more expensive valuation: OR is more expensive than 61.54% of the companies listed in the same industry.
The average S&P500 Price/Earnings ratio is at 27.13. OR is around the same levels.
A Price/Forward Earnings ratio of 27.98 indicates a quite expensive valuation of OR.
Based on the Price/Forward Earnings ratio, OR is valued a bit more expensive than the industry average as 69.23% of the companies are valued more cheaply.
OR's Price/Forward Earnings ratio indicates a valuation a bit more expensive than the S&P500 average which is at 22.76.
Industry RankSector Rank
PE 31.21
Fwd PE 27.98
OR.PA Price Earnings VS Forward Price EarningsOR.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

OR's Enterprise Value to EBITDA ratio is rather expensive when compared to the industry. OR is more expensive than 84.62% of the companies in the same industry.
OR's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 31.93
EV/EBITDA 20.54
OR.PA Per share dataOR.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60 80

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
The excellent profitability rating of OR may justify a higher PE ratio.
PEG (NY)7.1
PEG (5Y)3.02
EPS Next 2Y5.99%
EPS Next 3Y6.5%

3

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 1.74%, OR has a reasonable but not impressive dividend return.
Compared to an average industry Dividend Yield of 2.43, OR has a dividend in line with its industry peers.
OR's Dividend Yield is slightly below the S&P500 average, which is at 2.32.
Industry RankSector Rank
Dividend Yield 1.74%

5.2 History

On average, the dividend of OR grows each year by 11.22%, which is quite nice.
Dividend Growth(5Y)11.22%
Div Incr Years4
Div Non Decr Years4
OR.PA Yearly Dividends per shareOR.PA Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 2 4 6 8

5.3 Sustainability

56.41% of the earnings are spent on dividend by OR. This is a bit on the high side, but may be sustainable.
OR's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP56.41%
EPS Next 2Y5.99%
EPS Next 3Y6.5%
OR.PA Yearly Income VS Free CF VS DividendOR.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B
OR.PA Dividend Payout.OR.PA Dividend Payout, showing the Payout Ratio.OR.PA Dividend Payout.PayoutRetained Earnings

L'OREAL

EPA:OR (8/29/2025, 7:00:00 PM)

397.9

-4.45 (-1.11%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryPersonal Care Products
Earnings (Last)07-29 2025-07-29/amc
Earnings (Next)10-21 2025-10-21
Inst Owners15.17%
Inst Owner ChangeN/A
Ins Owners0.27%
Ins Owner ChangeN/A
Market Cap212.16B
Analysts69.44
Price Target396 (-0.48%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.74%
Yearly Dividend6.76
Dividend Growth(5Y)11.22%
DP56.41%
Div Incr Years4
Div Non Decr Years4
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)1.21%
PT rev (3m)1.43%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-1.51%
EPS NY rev (3m)-1.51%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.26%
Revenue NY rev (3m)-0.35%
Valuation
Industry RankSector Rank
PE 31.21
Fwd PE 27.98
P/S 4.88
P/FCF 31.93
P/OCF 25.6
P/B 6.4
P/tB 14
EV/EBITDA 20.54
EPS(TTM)12.75
EY3.2%
EPS(NY)14.22
Fwd EY3.57%
FCF(TTM)12.46
FCFY3.13%
OCF(TTM)15.54
OCFY3.91%
SpS81.56
BVpS62.14
TBVpS28.43
PEG (NY)7.1
PEG (5Y)3.02
Profitability
Industry RankSector Rank
ROA 11.37%
ROE 19.34%
ROCE 20.83%
ROIC 15.97%
ROICexc 17.68%
ROICexgc 33.8%
OM 19.98%
PM (TTM) 14.74%
GM 74.18%
FCFM 15.28%
ROA(3y)11.83%
ROA(5y)10.87%
ROE(3y)20.54%
ROE(5y)18.68%
ROIC(3y)16.33%
ROIC(5y)15.46%
ROICexc(3y)18.08%
ROICexc(5y)17.43%
ROICexgc(3y)36.23%
ROICexgc(5y)35.94%
ROCE(3y)21.48%
ROCE(5y)20.77%
ROICexcg growth 3Y-5.54%
ROICexcg growth 5Y4.43%
ROICexc growth 3Y-0.55%
ROICexc growth 5Y3.35%
OM growth 3Y1.46%
OM growth 5Y1.47%
PM growth 3Y1.16%
PM growth 5Y3.26%
GM growth 3Y0.14%
GM growth 5Y0.32%
F-Score7
Asset Turnover0.77
Health
Industry RankSector Rank
Debt/Equity 0.2
Debt/FCF 1.28
Debt/EBITDA 0.63
Cap/Depr 88.49%
Cap/Sales 3.78%
Interest Coverage 22.74
Cash Conversion 78.59%
Profit Quality 103.68%
Current Ratio 1.13
Quick Ratio 0.81
Altman-Z 7.36
F-Score7
WACC7.71%
ROIC/WACC2.07
Cap/Depr(3y)87.58%
Cap/Depr(5y)74.21%
Cap/Sales(3y)3.63%
Cap/Sales(5y)3.54%
Profit Quality(3y)96.35%
Profit Quality(5y)113.17%
High Growth Momentum
Growth
EPS 1Y (TTM)3.41%
EPS 3Y12.8%
EPS 5Y10.34%
EPS Q2Q%1.29%
EPS Next Y4.39%
EPS Next 2Y5.99%
EPS Next 3Y6.5%
EPS Next 5Y8.27%
Revenue 1Y (TTM)2.6%
Revenue growth 3Y10.44%
Revenue growth 5Y7.8%
Sales Q2Q%1.59%
Revenue Next Year2.4%
Revenue Next 2Y3.58%
Revenue Next 3Y4.11%
Revenue Next 5Y5.26%
EBIT growth 1Y8.09%
EBIT growth 3Y12.05%
EBIT growth 5Y9.39%
EBIT Next Year23.71%
EBIT Next 3Y11.82%
EBIT Next 5Y10.46%
FCF growth 1Y8.64%
FCF growth 3Y5.53%
FCF growth 5Y5.72%
OCF growth 1Y8.96%
OCF growth 3Y7.19%
OCF growth 5Y5.76%